Trial reportContrast media & molecular imaging2017
An Individually Optimized Protocol of Contrast Medium Injection in Enhanced CT Scan for Liver Imaging.
Trial report in Contrast media & molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Iodinated Contrast Media Dose Protocols for Computed Tomography Investigations of the Abdomen: A Systematic Review and Meta-Analysis.Journal of imaging · 2026Review
- Personalized Contrast Agent Volumes in Abdominal CT: Bridging Theory with Practice.Journal of the Belgian Society of Radiology · 2025Article
- Validation of a multi-parameter algorithm for personalized contrast injection protocol in liver CT.European radiology experimental · 2024Article
- Predicting the risk category of thymoma with machine learning-based computed tomography radiomics signatures and their between-imaging phase differences.Scientific reports · 2024Article
- Optimal Abdominal CT Image Quality in Non-Lean Patients: Customization of CM Injection Protocols and Low-Energy Acquisitions.Diagnostics (Basel, Switzerland) · 2023Article
- Evaluation of Iodinated Contrast Media Use in Abdominal CT Scans in Cancer Assessments: A Cross-Sectional Study in Lomé (Togo).Radiology research and practice · 2023Article
- A patient-informed approach to predict iodinated-contrast media enhancement in the liver.European journal of radiology · 2022Article
- Artificial Intelligence and Positron Emission Tomography Imaging Workflow:: Technologists' Perspective.PET clinics · 2022Review
- Prospective multicenter study on personalized and optimized MDCT contrast protocols: results on liver enhancement.European radiology · 2021Article
- An evaluation of DNA double strand break formation and excreted guanine species post whole body PET/CT procedure.Journal of radiation research · 2021Article
- An Individualized Contrast-Enhanced Liver Computed Tomography Imaging Protocol Based on Body Mass Index in 126 Patients Seen for Liver Cirrhosis.Medical science monitor : international medical journal of experimental and clinical research · 2021Article
- Artificial intelligence in diagnostic imaging: impact on the radiography profession.The British journal of radiology · 2020Review
- An anatomical study of the spinous process of the seventh cervical vertebrae based on the three-dimensional computed tomography reconstruction.Experimental and therapeutic medicine · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the effectiveness of a new individualized contrast medium injection protocol for enhanced liver CT scan. Methods: 324 patients who underwent plain and dual phase enhanced liver CT were randomly assigned to 2 groups: G1 ( Results: The mean contrast medium dose of G1 was statistically lower than that of G2. There were no significantly statistical differences in CT values and ΔHU of liver parenchyma during HAP, TLC values during HAP, and PVP between two groups. The CT values and ΔHU of liver parenchyma during PVP of G2 were significantly higher than those of G1. Two independent radiologists were both in substantial conformity in grading tumor conspicuity. Conclusion: Using the individually optimized injection protocol might reduce contrast medium dose without impacting on the imaging quality in enhanced liver CT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.